These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1942719)

  • 21. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
    Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
    Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
    Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
    Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical hysterectomy for stage 1 cervical carcinoma in Northern Ireland. A five year review.
    McClure N; Price J; Bond EB
    Ulster Med J; 1990 Oct; 59(2):183-6. PubMed ID: 2278117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?
    Finan MA; DeCesare S; Fiorica JV; Chambers R; Hoffman MS; Kline RC; Roberts WS; Cavanagh D
    Gynecol Oncol; 1996 Aug; 62(2):139-47. PubMed ID: 8751541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations.
    Massuger LF; Koper NP; Thomas CM; Dom KE; Schijf CP
    Gynecol Oncol; 1997 Mar; 64(3):473-6. PubMed ID: 9062153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic factors in uterine cervical and corpus cancer].
    Yoshioka T; Inoue Y; Hoshiai H; Noda K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1417-22. PubMed ID: 7668881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cervical cancer in women aged 35 and under:a new disease?].
    Dargent D; Kouakou F; Chomier M; Adeleine P
    Rev Fr Gynecol Obstet; 1991 Nov; 86(11):635-8. PubMed ID: 1780616
    [No Abstract]   [Full Text] [Related]  

  • 31. Radical hysterectomy--the treatment of choice for early-stage cervical carcinoma.
    Curtin JP
    Gynecol Oncol; 1996 Aug; 62(2):137-8. PubMed ID: 8751540
    [No Abstract]   [Full Text] [Related]  

  • 32. [Stages I and II of invasive cancer of the uterine cervix in young women: experience at the Gustave-Roussy Institute].
    Michel G; Castaigne D; Morice P; des Noettes R; Rey A; Gerbaulet A; Lhommé C; Prade M
    Bull Cancer Radiother; 1994; 81(4):418-26. PubMed ID: 7702929
    [No Abstract]   [Full Text] [Related]  

  • 33. [Investigation of prognostic factor and treatment mode for undifferentiated cervical carcinoma].
    Zhang Y; Li M; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jan; 35(1):45-7. PubMed ID: 11831951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamics of apparent and relative survival of patients with cervical cancer (population study)].
    Merabishvili VM; Laliantsi ÉI; Chepik OF; Subbotina OIu
    Vopr Onkol; 2012; 58(3):333-8. PubMed ID: 22888647
    [No Abstract]   [Full Text] [Related]  

  • 35. Examining the effect of minority status and neighborhood characteristics on cervical cancer survival outcomes.
    Lim JW; Ashing-Giwa KT
    Gynecol Oncol; 2011 Apr; 121(1):87-93. PubMed ID: 21183210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival from uterine cervical cancer in Mumbai (Bombay), India.
    Yeole BB; Sankaranarayanan R; Jussawalla DJ
    Int J Cancer; 1998 Oct; 78(3):394-5. PubMed ID: 9766580
    [No Abstract]   [Full Text] [Related]  

  • 37. [Presence of HCG subunits in the blood of women with cervical cancer].
    Kotarski J
    Ginekol Pol; 1986 Mar; 57(3):231-4. PubMed ID: 3732859
    [No Abstract]   [Full Text] [Related]  

  • 38. Apoptosis as predictor of response to radiotherapy in cervical carcinoma.
    Levine EL; Davidson SE; Roberts SA; Chadwick CA; Potten CS; West CM
    Lancet; 1994 Aug; 344(8920):472. PubMed ID: 7914578
    [No Abstract]   [Full Text] [Related]  

  • 39. Carcinoma of the cervix in women up to 35 years of age.
    Harte RJ; McAleer JJ; Atkinson RJ
    Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):120. PubMed ID: 2031882
    [No Abstract]   [Full Text] [Related]  

  • 40. Improved survival in cervical cancer cases in a rural Indian population.
    Jayant K; Rao RS; Nene BM; Dale PS; Nandakumar A
    Br J Cancer; 1996 Jul; 74(2):285-7. PubMed ID: 8688337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.